Patrick C. Wilson

Active 1998–2025

108
Papers
18,969
Citations
70
h-index
103
i10-index

Citations

Citations per year for Patrick C. Wilson1998: 5 citations1999: 8 citations2000: 13 citations2001: 14 citations2002: 23 citations2003: 30 citations2004: 38 citations2005: 44 citations2006: 25 citations2007: 41 citations2008: 47 citations2009: 42 citations2010: 57 citations2011: 122 citations2012: 141 citations2013: 165 citations2014: 192 citations2015: 206 citations2016: 287 citations2017: 300 citations2018: 321 citations2019: 1,036 citations2020: 1,103 citations2021: 1,092 citations2022: 757 citations2023: 615 citations2024: 782 citations2025: 409 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,034 citing papers, 36.5% of this breakdownChina: 584 citing papers, 7% of this breakdownUnited Kingdom: 544 citing papers, 6.6% of this breakdownGermany: 377 citing papers, 4.5% of this breakdownFrance: 312 citing papers, 3.8% of this breakdownCanada: 269 citing papers, 3.2% of this breakdownAustralia: 263 citing papers, 3.2% of this breakdownNetherlands: 256 citing papers, 3.1% of this breakdownSwitzerland: 219 citing papers, 2.6% of this breakdownJapan: 217 citing papers, 2.6% of this breakdownItaly: 167 citing papers, 2% of this breakdownSweden: 146 citing papers, 1.8% of this breakdown
0%36.5%Other 23.1%

Fields

  • Medicine60%
  • Immunology and Microbiology19.6%
  • Biochemistry, Genetics and Molecular Biology17%
  • Agricultural and Biological Sciences0.8%
  • Neuroscience0.6%
  • Nursing0.4%
  • Other1.6%

Topics

  • Influenza Virus Research Studies8.9%
  • T-cell and B-cell Immunology6.9%
  • Immune Cell Function and Interaction6.3%
  • Respiratory viral infections research5.3%
  • Monoclonal and Polyclonal Antibodies Research5.1%
  • SARS-CoV-2 and COVID-19 Research4.9%
  • Other62.6%

Coauthors

All papers

Open in search
  1. Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2019 cited by 592

  2. Natural polyreactive IgA antibodies coat the intestinal microbiota

    Authors: , , , , , , , , , - Science 2017 cited by 472

  3. A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adolfo García‐Sastre, Peter Palese, Florian Krammer - Nature Medicine 2020 cited by 358

  4. Innate and Adaptive Humoral Responses Coat Distinct Commensal Bacteria with Immunoglobulin A

    Authors: , , , , , , , , , , , - Immunity 2015 cited by 554

  5. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 576

  6. Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cell 2018 cited by 436

  7. Broadly neutralizing antibodies target a haemagglutinin anchor epitope

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lynda Coughlan, Andrew B. Ward, Patrick C. Wilson - Nature 2021 cited by 190

  8. Mycobiota-induced IgA antibodies regulate fungal commensalism in the gut and are dysregulated in Crohn’s disease

    Authors: , , , , , , , , , , , , , - Nature Microbiology 2021 cited by 145

  9. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus

    Authors: , , , , , , , , , , , , , , - Nature 2008 cited by 1,068

  10. NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

    Authors: , , , , , , , , , - mBio 2018 cited by 307

  11. Immune history profoundly affects broadly protective B cell responses to influenza

    Authors: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 426

  12. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection

    Authors: , , , - Journal of Clinical Investigation 2016 cited by 428

  13. Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation

    Authors: , , , , , , , , , , , , - Science Immunology 2017 cited by 273

  14. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2011 cited by 802

  15. The influenza virus hemagglutinin head evolves faster than the stalk domain

    Authors: , , , , - Scientific Reports 2018 cited by 242

  16. From Original Antigenic Sin to the Universal Influenza Virus Vaccine

    Authors: , , , - Trends in Immunology 2017 cited by 279

  17. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans

    Authors: , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 245

  18. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 187

  19. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gregory C. Ippolito, Florian Krammer, Stephen R. Quake, Peter D. Kwong, George Georgiou - Nature Medicine 2016 cited by 304

  20. First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes

    Authors: , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 80

  21. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 598

  22. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yoshihiro Kawaoka, Patrick C. Wilson - Immunity 2021 cited by 146

  23. Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - PLoS Pathogens 2016 cited by 145

  24. Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2019 cited by 165